Pacira BioSciences
PCRX
PCRX
232 hedge funds and large institutions have $1.21B invested in Pacira BioSciences in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 84 increasing their positions, 78 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
6% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 32
1% less funds holding
Funds holding: 235 → 232 (-3)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
232
Holding in Top 10
1
Calls
$7.02M
Puts
$2.2M
Top Buyers
| 1 | +$21.8M | |
| 2 | +$14.5M | |
| 3 | +$13.5M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$12.3M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$10.9M |
Top Sellers
| 1 | -$33.1M | |
| 2 | -$26.5M | |
| 3 | -$9.47M | |
| 4 |
JP Morgan Chase
New York
|
-$7.42M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$7.06M |
